MIRXES-B Appoints Zeng Guowei as Independent Non-Executive Director

Stock News06-01

MIRXES-B (02629) has announced that Ms. Ma Luling has resigned from her positions as Independent Non-Executive Director, Chairman of the Company's Nomination Committee, and member of the Remuneration Committee, effective immediately on May 29, 2026, to focus on other business pursuits and commitments. On May 31, 2026, the Board of Directors resolved to accept Ms. Ma's resignation. On the same day, the Board resolved to appoint: (a) Dr. Lin Qianli as a member of the Nomination Committee; (b) Mr. Fang Xiao as Chairman of the Nomination Committee; and (c) Dr. Zhu Xingfen as a member of the Remuneration Committee, all effective immediately. Mr. Zeng Guowei was appointed as an Independent Non-Executive Director on May 31, 2026, effective immediately, to fill the temporary vacancy created by Ms. Ma's resignation. Accordingly, under the Company's Third Amended and Restated Memorandum and Articles of Association, Mr. Zeng's term will last until the first annual general meeting of the Company following his appointment (i.e., the upcoming annual general meeting), subject to re-election by shareholders at that meeting. Concurrently with his appointment as Independent Non-Executive Director, Mr. Zeng was also appointed as a member of the Company's Nomination Committee, Remuneration Committee, Audit Committee, and Independent Investigation Committee, effective immediately.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment